Page 1 | Search Results | Hematology, ASH Education Program

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Blood manipulation: current challenges from an anti-doping perspective

Jakob Mørkeberg

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 627–631.

https://doi.org/10.1182/asheducation-2013.1.627

Published: 2013

Journal Articles

Hemostatic defects in liver and renal dysfunction

Pier Mannuccio Mannucci, Armando Tripodi

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 168–173.

https://doi.org/10.1182/asheducation.V2012.1.168.3798232

Published: 2012

Journal Articles

Management of RBC-Transfusion Dependence

Magda Melchert, Alan F. List

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 398–404.

https://doi.org/10.1182/asheducation-2007.1.398

Published: 2007

Journal Articles

Fetal Globin Induction—Can It Cure β Thalassemia?

Susan P. Perrine

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 38–44.

https://doi.org/10.1182/asheducation-2005.1.38

Published: 2005

Journal Articles

Update on Supportive Care and New Therapies: Immunomodulatory Drugs, Growth Factors and Epigenetic-Acting Agents

Eva Hellström-Lindberg

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 161–166.

https://doi.org/10.1182/asheducation-2005.1.161

Published: 2005

Journal Articles

Erythropoietin: A Paradigm for the Development of Practice Guidelines

J. Douglas Rizzo, Jerome Seidenfeld, Margaret Piper, Naomi Aronson, Alan Lichtin, Timothy J. Littlewood

Hematology Am Soc Hematol Educ Program (2001) 2001 (1): 10–30.

https://doi.org/10.1182/asheducation-2001.1.10

Published: 2001

Journal Articles

Achievements in Understanding and Treatment of Myelodysplastic Syndromes

Eva Hellström-Lindberg, Cheryl Willman, A. John Barrett, Yogen Saunthararajah

Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 110–132.

https://doi.org/10.1182/asheducation.V2000.1.110.110

Published: 2000

NARROW

Blood manipulation: current challenges from an anti-doping perspective

Hemostatic defects in liver and renal dysfunction

Management of RBC-Transfusion Dependence

Fetal Globin Induction—Can It Cure β Thalassemia?

Update on Supportive Care and New Therapies: Immunomodulatory Drugs, Growth Factors and Epigenetic-Acting Agents

Erythropoietin: A Paradigm for the Development of Practice Guidelines

Achievements in Understanding and Treatment of Myelodysplastic Syndromes

ASH Publications

American Society of Hematology

Blood manipulation: current challenges from an anti-doping perspective

Hemostatic defects in liver and renal dysfunction

Management of RBC-Transfusion Dependence

Fetal Globin Induction—Can It Cure β Thalassemia?

Update on Supportive Care and New Therapies: Immunomodulatory Drugs, Growth Factors and Epigenetic-Acting Agents

Erythropoietin: A Paradigm for the Development of Practice Guidelines

Achievements in Understanding and Treatment of Myelodysplastic Syndromes

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only